SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0)
Clinical trials for SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0) explained in plain language.
Never miss a new study
Get alerted when new SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0) trials appear
Sign up with your email to follow new studies for SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope to shield kidneys in sickle cell disease
Disease control Not yet recruitingThis study is testing if a drug called empagliflozin can help protect the kidneys of people with sickle cell anemia. It will involve 20 adults who already show early signs of kidney damage. Researchers will measure changes in urine and blood tests, and use a special kidney scan, …
Matched conditions: SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0)
Phase: PHASE2 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New blood treatment could give sickle cell patients more time between transfusions
Disease control Not yet recruitingThis study is testing whether blood processed with a special device to keep it low in oxygen works better than regular blood for transfusions in people with sickle cell disease. The goal is to see if this new method helps patients go longer between transfusions and reduces painfu…
Matched conditions: SICKLE CELL ANEMIA (HBSS, OR HBSΒ-THALASSEMIA0)
Phase: NA • Sponsor: Hemanext • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC